Know Cancer

or
forgot password

Evaluation of the Role of Human Papillomavirus Testing and p16 Expression in the Management of Patients Undergoing Cervical Cancer Screening


N/A
18 Years
N/A
Open (Enrolling)
Female
Cervical Cancer

Thank you

Trial Information

Evaluation of the Role of Human Papillomavirus Testing and p16 Expression in the Management of Patients Undergoing Cervical Cancer Screening


Inclusion Criteria:



- 18 years and older

- Ability to speak and clearly understand English

- Female patients

Exclusion Criteria:

- No previous history of Cervical Cancer Treatment(LEEP,Laser,Cone etc.)

- Women who have had Pap smears within the previous 10 months

- Women under the age of 18.

- Women who are pregnant.

- Inability to give informed consent in English

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To provide cervical cancer screening (Pap smear, HPV test and/or p16 tests) to determine whether further intervention (colposcopy) is required

Outcome Time Frame:

1st visit, 12 months, 18 months follow up

Safety Issue:

No

Principal Investigator

Joan K Murphy, MD,FRCSC

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Health Network, Toronto

Authority:

Canada: Canadian Institutes of Health Research

Study ID:

Pap Smear Study

NCT ID:

NCT00743626

Start Date:

December 2006

Completion Date:

January 2011

Related Keywords:

  • Cervical Cancer
  • Pap test
  • HPV
  • Healthy patients screened for cervical cancer tests.
  • Uterine Cervical Neoplasms

Name

Location